Article Versions Notes

Lan W, Tam K-W, Chen J-T, Cata JP, Cherng Y-G, Chou Y-Y, Chien L-N, Chang C-L, Tai Y-H, Chu L-M. Cost-Effectiveness of Sugammadex Versus Neostigmine to Reverse Neuromuscular Blockade in a University Hospital in Taiwan: A Propensity Score-Matched Analysis. Healthcare. 2023; 11(2):240. https://doi.org/10.3390/healthcare11020240

Lan, Winnie, Ka-Wai Tam, Jui-Tai Chen, Juan P. Cata, Yih-Giun Cherng, Yun-Yun Chou, Li-Nien Chien, Chia-Li Chang, Ying-Hsuan Tai, and Lu-Min Chu. 2023. "Cost-Effectiveness of Sugammadex Versus Neostigmine to Reverse Neuromuscular Blockade in a University Hospital in Taiwan: A Propensity Score-Matched Analysis" Healthcare 11, no. 2: 240. https://doi.org/10.3390/healthcare11020240

Lan, W., Tam, K.-W., Chen, J.-T., Cata, J. P., Cherng, Y.-G., Chou, Y.-Y., Chien, L.-N., Chang, C.-L., Tai, Y.-H., & Chu, L.-M. (2023). Cost-Effectiveness of Sugammadex Versus Neostigmine to Reverse Neuromuscular Blockade in a University Hospital in Taiwan: A Propensity Score-Matched Analysis. Healthcare, 11(2), 240. https://doi.org/10.3390/healthcare11020240